TAG overview

GRI Content Index: Social Standards

GRI Standards and Disclosure Number

Comment

Reference

GRI 401: EMPLOYMENT 2016

103-1

Explanation of the material topic and its Boundary

 

Attractive employer
Diversity
Health and safety
Human rights
Materiality analysis

103-2

The management approach and its components

 

103-3

Evaluation of the management approach

 

401-1

New employee hires and employee turnover

 

Indicators: employees

401-2

Benefits provided to full-time employees that are not provided to temporary or part-time employees

At Merck KGaA, Darmstadt, Germany (22% of the company's total workforce), part-time employees receive the same job benefits as full-time workers. Employees with temporary contracts, however, are not entitled to all company benefits, such as a company pension.

Indicators: employees
Attractive employer

401-3

Parental leave

 

Attractive employer
Indicators: employees

GRI 402: LABOR/MANAGEMENT RELATIONS 2016

103-1

Explanation of the material topic and its Boundary

 

Attractive employer
Health and safety
Employee engagement
Materiality analysis

103-2

The management approach and its components

 

103-3

Evaluation of the management approach

 

402-1

Minimum notice periods regarding operational changes

The regulations on periods of notice vary worldwide. We apply the rules that are in force locally. There is no need for us to track periods of notice at Group level.

 

GRI 403: OCCUPATIONAL HEALTH AND SAFETY 2018

103-1

Explanation of the material topic and its Boundary

 

Health and safety
Materiality analysis

103-2

The management approach and its components

 

103-3

Evaluation of the management approach

 

403-1

Occupational health and safety management system

 

Health and safety

403-2

Hazard identification, risk assessment, and incident investigation

 

Health and safety

403-3

Occupational health services

 

Health and safety

403-4

Worker participation, consultation, and communication on occupational health and safety

Occupational health and safety committees are required by law in Germany. All employees of Merck KGaA, Darmstadt, Germany are therefore represented by such committees, which operate at the site level. These employees account for around 22% of our total workforce. The majority of facilities outside Germany also have health and safety committees to represent their employees. Each individual site is responsible for arranging and maintaining such committees.

Health and safety issues are governed Group-wide by our EHS Policy. The organizational implementation of the policy is the responsibility of our individual sites and is subject to local laws and regulations. Merck KGaA, Darmstadt, Germany, which accounts for approximately 22% of our total workforce, has bylaws on occupational health and safety in place.

Health and safety

403-5

Worker training on occupational health and safety

 

Health and safety

403-6

Promotion of worker health

 

Health and safety

403-7

Prevention and mitigation of occupational health and safety impacts directly linked by business relationships

 

Health and safety

403-8

Workers covered by an occupational health and safety management system

 

Health and safety

403-9

Work-related injuries

We have identified the lost time injury rate (LTIR) as a key performance indicator for our company.

Health and safety
Indicators: employees

403-10

Work-related ill health

 

Indicators: employees

GRI 404: TRAINING AND EDUCATION 2016

103-1

Explanation of the material topic and its Boundary

 

Attractive employer
Good leadership
Diversity
Materiality analysis

103-2

The management approach and its components

 

103-3

Evaluation of the management approach

 

404-1

Average hours of training per year per employee

We do not keep track of the average hours our employees spend on vocational training and continuing education because this indicator does not have any bearing on the quality or success of our efforts.

Compliance
Responsible marketing
Interactions with health systems
Animal welfare
Patient safety
Product-related crime
Transport and warehouse safety
Attractive employer
Diversity
Health and safety
Good leadership
Environmental stewardship
Plant and process safety

404-2

Programs for upgrading employee skills and transition assistance programs

 

Attractive employer
Diversity
Good leadership

404-3

Percentage of employees receiving regular performance and career development reviews

 

Attractive employer
Indicators: employees

GRI 405: DIVERSITY AND EQUAL OPPORTUNITY 2016

103-1

Explanation of the material topic and its Boundary

 

Diversity
Attractive employer
Materiality analysis
Objectives of the Supervisory Board with respect to its position

103-2

The management approach and its components

 

103-3

Evaluation of the management approach

 

405-1

Diversity of governance bodies and employees

Since there is no globally uniform definition of the term “minority”, we do not record this sort of data. Moreover, many countries in which we operate have strict data privacy regulations governing the recording of personal employee data.

Diversity
Indicators: employees
The Executive Board
The Supervisory Board
Objectives of the Supervisory Board with respect to its position

405-2

Ratio of basic salary and remuneration of women to men

The salaries we offer are predicated on the respective job description and are based on our Global Job Catalog, which has fixed salary bands that are identical for men and women. Variable salary components that fall under performance-based compensation are paid on the basis of whether mutually agreed targets have been achieved. A performance management system governs this process.

Attractive employer

GRI 406: NON-DISCRIMINATION 2016

103-1

Explanation of the material topic and its Boundary

 

Diversity
Materiality analysis

103-2

The management approach and its components

 

103-3

Evaluation of the management approach

 

406-1

Incidents of discrimination and corrective actions taken

 

Diversity

GRI 407: FREEDOM OF ASSOCIATION AND COLLECTIVE BARGAINING 2016

103-1

Explanation of the material topic and its Boundary

 

Supply chain standards
Mica supply chain
Attractive employer
Human rights
Compliance
Materiality analysis

103-2

The management approach and its components

 

103-3

Evaluation of the management approach

 

407-1

Operations and suppliers in which the right to freedom of association and collective bargaining may be at risk

 

Supply chain standards
Mica supply chain
Human rights
Attractive employer

GRI 408: CHILD LABOR 2016

103-1

Explanation of the material topic and its Boundary

 

Supply chain standards
Mica supply chain
Human rights
Attractive employer
Compliance
Materiality analysis

103-2

The management approach and its components

 

103-3

Evaluation of the management approach

 

408-1

Operations and suppliers at significant risk for incidents of child labor

 

Supply chain standards
Mica supply chain
Human rights
Attractive employer
Indicators: employees

GRI 409: FORCED OR COMPULSORY LABOR 2016

103-1

Explanation of the material topic and its Boundary

 

Supply chain standards
Mica supply chain
Attractive employer
Human rights
Compliance
Materiality analysis

103-2

The management approach and its components

 

103-3

Evaluation of the management approach

 

409-1

Operations and suppliers at significant risk for incidents of forced or compulsory labor

 

Supply chain standards
Mica supply chain
Attractive employer
Human rights

GRI 412: HUMAN RIGHTS ASSESSMENT 2016

103-1

Explanation of the material topic and its Boundary

 

Human rights
Compliance
Materiality analysis

103-2

The management approach and its components

 

103-3

Evaluation of the management approach

 

412-1

Operations that have been subject to human rights reviews or impact assessments

 

Human rights

412-2

Employee training on human rights policies or procedures

 

Human rights

412-3

Significant investment agreements and contracts that include human rights clauses or that underwent human rights screening

 

Human rights

GRI 414: SUPPLIER SOCIAL ASSESSMENT 2016

103-1

Explanation of the material topic and its Boundary

 

Supply chain standards
Mica supply chain
Materiality analysis

103-2

The management approach and its components

 

103-3

Evaluation of the management approach

 

414-1

New suppliers that were screened using social criteria

 

Supply chain standards
Mica supply chain

414-2

Negative social impacts in the supply chain and actions taken

 

Supply chain standards
Mica supply chain

GRI 415: PUBLIC POLICY 2016

103-1

Explanation of the material topic and its Boundary

 

Stakeholder dialogue
Materiality analysis

103-2

The management approach and its components

 

103-3

Evaluation of the management approach

 

415-1

Political contributions

 

Stakeholder dialogue

GRI 416: CUSTOMER HEALTH AND SAFETY 2016

103-1

Explanation of the material topic and its Boundary

 

Patient safety
Responsible marketing
Interactions with health systems
Clinical studies
Chemical product safety
Sustainable product design
Plant and process safety
Materiality analysis
Report on Risks and Opportunities

103-2

The management approach and its components

 

103-3

Evaluation of the management approach

 

416-1

Assessment of the health and safety impacts of product and service categories

 

Patient safety
Clinical studies
Chemical product safety
Sustainable product design
Plant and process safety

416-2

Incidents of non-compliance concerning the health and safety impacts of products and services

As applicable, we report on risks from litigation and legal proceedings in our Report on Risks and Opportunities.

Report on Risks and Opportunities

GRI 417: MARKETING AND LABELING 2016

103-1

Explanation of the material topic and its Boundary

 

Patient safety
Chemical product safety
Responsible marketing
Interactions with health systems
Materiality analysis

103-2

The management approach and its components

 

103-3

Evaluation of the management approach

 

417-1

Requirements for product and service information and labeling

Within our businesses, product labels are both important and mandatory. All pharmaceuticals and chemicals are subject to reporting and notification requirements that we fulfill. The individual requirements are reported in the respective chapters.

Patient safety
Responsible marketing
Interactions with health systems
Chemical product safety

417-2

Incidents of non-compliance concerning product and service information and labeling

 

Patient safety
Chemical product safety
Report on Risks and Opportunities

417-3

Incidents of non-compliance concerning marketing communications

As applicable, we report on risks from litigation and legal proceedings in our Report on Risks and Opportunities.

Responsible marketing
Report on Risks and Opportunities

GRI 418: CUSTOMER PRIVACY 2016

103-1

Explanation of the material topic and its Boundary

 

Clinical studies
Compliance
Materiality analysis

103-2

The management approach and its components

 

103-3

Evaluation of the management approach

 

418-1

Substantiated complaints concerning breaches of customer privacy and losses of customer data

 

Indicators: business ethics
Clinical studies
Compliance

GRI 419: SOCIOECONOMIC COMPLIANCE 2016

103-1

Explanation of the material topic and its Boundary

 

Compliance
Materiality analysis
Report on Risks and Opportunities

103-2

The management approach and its components

 

103-3

Evaluation of the management approach

 

419-1

Non-compliance with laws and regulations in the social and economic area

As applicable, we report on risks from litigation and legal proceedings in our Report on Risks and Opportunities.

Indicators: business ethics
Report on Risks and Opportunities

 

 

 

 

Additional material topics

ETHICAL CONDUCT (bioethics, clinical studies, animal welfare)

103-1

Explanation of the material topic and its Boundary

 

Bioethics
Clinical studies
Animal welfare
Materiality analysis

103-2

The management approach and its components

 

103-3

Evaluation of the management approach

 

HEALTH FOR ALL (access to health, prices of medicines, health awareness)

103-1

Explanation of the material topic and its Boundary

 

Global strategy
Focus programs
Open innovation sharing
Prices of medicines
Health awareness
Materiality analysis

103-2

The management approach and its components

 

103-3

Evaluation of the management approach

 

PRODUCT-RELATED CRIME

103-1

Explanation of the material topic and its Boundary

 

Product-related crime
Materiality analysis

103-2

The management approach and its components

 

103-3

Evaluation of the management approach

 

COMMUNITY INVOLVEMENT

103-1

Explanation of the material topic and its Boundary

 

Community involvement
Global Health
Broad Minds
Materiality analysis

103-2

The management approach and its components

 

103-3

Evaluation of the management approach

 

WORK 4.0

103-1

Explanation of the material topic and its Boundary

 

Attractive employer
Materiality analysis

103-2

The management approach and its components

 

103-3

Evaluation of the management approach

 

Cookie Disclaimer

This website uses 'cookies' to give you the best, most relevant experience. Using this website means you’re OK with this. You can change which cookies are set at any time - and find out more about them in our cookie policy. Privacy Statement